Is Cs-131 or I-125 or Pd-103 the “Ideal” Isotope for Prostate Boost Brachytherapy?–A Dosimetric View Point

International Journal of Radiation Oncology Biology Physics

November 1, 2007

Related posts

Is there Decreased Duration of Acute Urinary and Bowel Symptoms after Prostate Brachytherapy with Cesium 131 Radioisotope?

Authors: S.G. DeFoe, S. Beriwal, R. Smith, R. Benoit

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

W. James Morris, MD, FRCPC, W. James Morris MD, FRCPC, Scott Tyldesley, MD, FRCPC, …

The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants.

Authors: Armpilia CI, Dale RG, Coles IP, Jones B, Antipas V.

Cesium131 Prostate Brachytherapy: An early experience

Authors: B. Moran

Company

Brachytherapy

Theranostics

Newsletter

Want to keep up-to-date on news and information?

Company

Newsletter

Want to keep up-to-date on news and information?

©2023. All rights reserved. Terms & Privacy | Privacy Policy

Scroll to top